ω-3 Intake in patients with retinitis pigmentosa receiving vitamin A-Reply.
作者信息
Berson Eliot L, Rosner Bernard, Sandberg Michael A, Weigel-Difranco Carol, Willett Walter C
出版信息
JAMA Ophthalmol. 2013 Feb;131(2):267-8. doi: 10.1001/jamaophthalmol.2013.1722.
Abstract
摘要
相似文献
1
ω-3 Intake in patients with retinitis pigmentosa receiving vitamin A-Reply.
JAMA Ophthalmol. 2013 Feb;131(2):267-8. doi: 10.1001/jamaophthalmol.2013.1722.
2
ω-3 Intake in patients with retinitis pigmentosa receiving vitamin A.
JAMA Ophthalmol. 2013 Feb;131(2):267-8. doi: 10.1001/jamaophthalmol.2013.590.
3
ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
Arch Ophthalmol. 2012 Jun;130(6):707-11. doi: 10.1001/archophthalmol.2011.2580.
4
Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
JAMA Ophthalmol. 2018 May 1;136(5):490-495. doi: 10.1001/jamaophthalmol.2018.0590.
5
How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?
Arch Ophthalmol. 2010 Apr;128(4):493-5. doi: 10.1001/archophthalmol.2010.46.
6
Letter from the DSMC regarding a clinical trial of lutein in patients with retinitis pigmentosa.
Arch Ophthalmol. 2011 May;129(5):675; author reply 675-6. doi: 10.1001/archophthalmol.2011.76.
7
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
Arch Ophthalmol. 2004 Sep;122(9):1306-14. doi: 10.1001/archopht.122.9.1306.
8
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Arch Ophthalmol. 2010 Apr;128(4):403-11. doi: 10.1001/archophthalmol.2010.32.
9
Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1298-304. doi: 10.1167/iovs.06-0971.
10
Disease course of patients with pericentral retinitis pigmentosa.
Am J Ophthalmol. 2005 Jul;140(1):100-6. doi: 10.1016/j.ajo.2005.02.038.
Zotero 插件